Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
MT-II was designed and characterised through the systematic melanocortin peptide structure-activity relationship programme in Victor Hrubys laboratory at the University of Arizona , the same programme that produced MT-1 , with the cyclisation strategy introduced to further constrain the pharmacophore into a receptor-binding conformation that simultaneously increases potency, metabolic stability, and the receptor subtype selectivity profile that distinguishes MT-II from the linear tridecapeptide MT-1
Thomason, H
Whitener MEB, Stanstrup J, Carlin S, Divol B, Du Toit M, Vrhovsek U
Nie zaleca si stosowania przez kobiety w ciy i karmice piersi
n = 8613) groups
Adjust How You Eat Choose Smaller Portions: Large meals may overwhelm the digestive system when GLP-1 medications slow the movement of food through the stomach
US$ 23.87
US$ 29.54
US$ 21.89
US$ 29.64
US$ 20.91
US$ 27.40
US$ 25.39
